Wenfeng Fang
Sun Yat-sen University(CN)Sun Yat-sen University Cancer Center(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation(2015)676 cited
- → Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials(2018)500 cited
- → Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial(2021)439 cited
- → EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy(2014)382 cited
- → KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma(2017)288 cited
- → The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs(2015)243 cited
- → Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer(2019)235 cited
- → Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes(2017)215 cited
- → Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas(2016)200 cited
- → Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer(2016)200 cited